236 related articles for article (PubMed ID: 12126895)
1. Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.
Kojima Y; Xin KQ; Ooki T; Hamajima K; Oikawa T; Shinoda K; Ozaki T; Hoshino Y; Jounai N; Nakazawa M; Klinman D; Okuda K
Vaccine; 2002 Jul; 20(23-24):2857-65. PubMed ID: 12126895
[TBL] [Abstract][Full Text] [Related]
2. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
Askew D; Chu RS; Krieg AM; Harding CV
J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
[TBL] [Abstract][Full Text] [Related]
3. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
[TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
Horner AA; Datta SK; Takabayashi K; Belyakov IM; Hayashi T; Cinman N; Nguyen MD; Van Uden JH; Berzofsky JA; Richman DD; Raz E
J Immunol; 2001 Aug; 167(3):1584-91. PubMed ID: 11466380
[TBL] [Abstract][Full Text] [Related]
5. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.
Sparwasser T; Koch ES; Vabulas RM; Heeg K; Lipford GB; Ellwart JW; Wagner H
Eur J Immunol; 1998 Jun; 28(6):2045-54. PubMed ID: 9645386
[TBL] [Abstract][Full Text] [Related]
6. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
[TBL] [Abstract][Full Text] [Related]
7. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
[TBL] [Abstract][Full Text] [Related]
8. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of HIV-1 subtype C vaccine constructs induced immune response in mice by CpG motif 1826-ODN.
Aggarwal P; Pandey RM; Seth P
Viral Immunol; 2005; 18(1):213-23. PubMed ID: 15802966
[TBL] [Abstract][Full Text] [Related]
10. CpG DNA is an effective oral adjuvant to protein antigens in mice.
McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
12. Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.
Vinner L; Nielsen HV; Bryder K; Corbet S; Nielsen C; Fomsgaard A
Vaccine; 1999 Apr; 17(17):2166-75. PubMed ID: 10367950
[TBL] [Abstract][Full Text] [Related]
13. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.
Barnett SW; Rajasekar S; Legg H; Doe B; Fuller DH; Haynes JR; Walker CM; Steimer KS
Vaccine; 1997 Jun; 15(8):869-73. PubMed ID: 9234536
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.
Hiraoka K; Yamamoto S; Otsuru S; Nakai S; Tamai K; Morishita R; Ogihara T; Kaneda Y
J Immunol; 2004 Oct; 173(7):4297-307. PubMed ID: 15383558
[TBL] [Abstract][Full Text] [Related]
16. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.
Cho HJ; Hayashi T; Datta SK; Takabayashi K; Van Uden JH; Horner A; Corr M; Raz E
J Immunol; 2002 May; 168(10):4907-13. PubMed ID: 11994440
[TBL] [Abstract][Full Text] [Related]
17. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
[TBL] [Abstract][Full Text] [Related]
18. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
Davila E; Celis E
J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
[TBL] [Abstract][Full Text] [Related]
19. CpG motifs for optimization of DNA vaccines.
Davis HL
Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors.
Coban C; Ishii KJ; Gursel M; Klinman DM; Kumar N
J Leukoc Biol; 2005 Sep; 78(3):647-55. PubMed ID: 15961575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
